C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/5377 (2006.01) A61P 7/02 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2528233
The invention relates to novel compounds of formula (I), in which Het, R1, R2 and R3 have the significance specified in patent claim 1, said compounds being coagulation factor Xa inhibitors and used for preventing and/or curing thromboembolic diseases and treating tumors.
L'invention concerne de nouveaux composés de formule (I), dans laquelle Het, R?1¿, R?2¿ et R?3¿ ont la signification indiquée à la revendication 1, ces composés étant des inhibiteurs du facteur de coagulation Xa et servant à la prophylaxie et/ou à la thérapie de maladies thromboemboliques et au traitement de tumeurs.
Cezanne Bertram
Dorsch Dieter
Gleitz Johannes
Mederski Werner
Tsaklakidis Christos
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Aroylsemicarbazide derivatives against thromboembolic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aroylsemicarbazide derivatives against thromboembolic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aroylsemicarbazide derivatives against thromboembolic diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1379039